MedTrace Logo

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

NCT06503367 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-08-19

No results posted yet for this study

Summary

The goal of this observational study is to understand how young children with LAMA2-related dystrophy move and change over time. We will also learn about how this condition impacts other body systems.

Participants will undergo:

* Neuromuscular assessments
* Blood collections
* Swallowing and breathing assessments
* Questionnaires

Conditions

  • LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)

Sponsors & Collaborators

Principal Investigators

  • Anne M Connolly, MD · Nationwide Childrens Hospital

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-12
Primary Completion
2028-09-30
Completion
2028-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06503367 on ClinicalTrials.gov